Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

ABSTRACT: This trial is designed to investigate the safety, response rates and survival outcomes of patients with advanced solid tumors by infusion of CTLA4, PD1 and PDL1 antibodies combination through venous (IV), artery (IA) or intra-tumor (IT).

DISEASE(S): Ovary Cancer,Solid Tumor,Lung Cancer,Sarcoma,Cervical Cancer,Colorectal Cancer,Liver Cancer,Breast Cancer,Pancreas Cancer,Gastric Cancer,Esophageal Cancer,Head And Neck Cancer,Ovarian Neoplasms,Pancreatic Neoplasms

PROVIDER: 2400644 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR